FDA Approves New Treatment For Adults With Relapsed Or Refractory Large-B-Cell Lymphoma | FDA News
For Immediate Release: February 05, 2021 Today, the U.S. Food and Drug Administration approved Breyanzi (lisocabtagene maraleucel), a cell-based gene therapy to treat adult patients with certain types of large…